Liposomes were the first nanoscale drug to be approved for clinical use in 1995. Since then,
the technology has grown considerably, and pioneering recent work in liposome-based …

Liposomes are lipid based vesicular systems that offer novel platform for versatile drug
delivery to target cell. Liposomes were first reported by Bangham and his co-workers in …

The first closed bilayer phospholipid systems, called liposomes, were described in 1965 and
soon were proposed as drug delivery systems. The pioneering work of countless liposome …

Since the discovery of liposomes or lipid vesicles derived from self‐forming enclosed lipid
bilayers upon hydration, liposome drug delivery systems have played a significant role in …

The application of liposomes to assist drug delivery has already had a major impact on
many biomedical areas. They have been shown to be beneficial for stabilizing therapeutic …

Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which
facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active …

Liposomes have been considered promising and versatile drug vesicles. Compared with
traditional drug delivery systems, liposomes exhibit better properties, including site …

In the 1980s, the center of entrepreneurial activity for the application of liposome science to
medicine took the form of a company called Vestar Inc.(which became NeXstar …

Liposomal technology has been widely used in the pharmaceutical field for the preparation
of nano-sized drug delivery systems based on natural or synthetic lipids. Liposomes …

Introduction: Pharmacotherapy is limited by the inefficient drug targeting of non-healthy
cells/tissues. In this pharmacological landscape, liposomes are contributing to the impulse …